Prescription Required
Inclusive of all taxes
In Treatment of Type 2 diabetes mellitus Lyxumia 10 Solution for Injection is an injectable medicine that helps to control high blood glucose (sugar) levels. Lowering blood glucose levels is an essential part of managing diabetes. It helps reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Proper control of diabetes may also lessen your risk of having a heart attack or stroke. You will need to learn exactly how, where, and when to inject this insulin for it to be most effective. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
It is unsafe to consume alcohol with Lyxumia 10 Solution for Injection.
Information regarding the use of Lyxumia 10 Solution for Injection during pregnancy is not available. Please consult your doctor.
Lyxumia 10 Solution for Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Lyxumia 10 Solution for Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Lyxumia 10 Solution for Injection may be needed. Please consult your doctor. Limited information is available on the use of Lyxumia 10 Solution for Injection in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
There is limited information available on the use of Lyxumia 10 Solution for Injection in patients with liver disease. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More